Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes

Ronald A. Cohen, Jaroslaw Harezlak, Assawin Gongvatana, Steven Buchthal, Giovanni Schifitto, Uraina Clark, Robert Paul, Michael Taylor, Paul Thompson, David Tate, Jeffery Alger, Mark Brown, Jianhui Zhong, Thomas Campbell, Elyse Singer, Eric Daar, Deborah McMahon, Yuen Tso, Constantin Yiannoutsos, Bradford Navia

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Cerebral metabolite disturbances occur among human immunodeficiency virus (HIV)-infected people, and are thought to reflect neuropathology, including proinflammatory processes, and neuronal loss. HIV-associated cortical atrophy continues to occur, though its basis is not well understood, and the relationship of cerebral metabolic disturbance to structural brain abnormalities in HIV has not been well delineated. We hypothesized that metabolite disturbances would be associated with reduced cortical and subcortical volumes. Cerebral volumes were measured in 67 HIV-infected people, including 10 people with mild dementia (acquired immunodeficiency syndrome [AIDS] dimentia complex [ADC] stage >1) via automated magnetic resonance imaging (MRI) segmentation. Magnetic resonance spectroscopy (MRS) was used to measure levels of cerebral metabolites N-acetylaspartate (NAA), myo-inositol (MI), choline-containing compounds (Cho), glutamate/glutamine (Glx), and creatine (Cr) from three brain regions (frontal gray matter, frontal white matter, basal ganglia). Analyses were conducted to examine the associations between MRS and cerebral volumetric measures using both absolute and relative metabolite concentrations. NAA in the mid-frontal gray matter was most consistently associated with cortical (global, frontal, and parietal), ventricular, and caudate volumes based on analysis of absolute metabolite levels, whereas temporal lobe volume was associated with basal ganglia NAA and Glx, and Cho concentrations in the frontal cortex and basal ganglia. Hippocampal volume was associated with frontal white matter NAA, whereas thalamic volume was associated with both frontal white matter NAA and basal ganglia Glx. Analyses of relative metabolite concentrations (referenced to Cr) yielded weaker effects, although more metabolites were retained as significant predictors in the models than the analysis of absolute concentrations. These findings demonstrate that reduced cortical and subcortical volumes, which have been previously found to be linked to HIV status and history, are also strongly associated with the degree of cerebral metabolite disturbance observed via MRS. Reduced cortical and hippocampal volumes were most strongly associated with decreased NAA, though reduced Glx also tended to be associated with reduced cortical and subcortical volumes (caudate and thalamus) as well, suggesting both neuronal and glial disturbances. Interestingly, metabolite-volumetric relationships were not limited to the cortical region from which MRS was measured, possibly reflecting shared pathophysiological processes. The relationships between Cho and volumetric measures suggest a complicated relationship possibly related to the effects of inflammatory processes on brain volume. The findings demonstrate the relationship between MRI-derived measures of cerebral metabolite disturbances and structural brain integrity, which has implication in understanding HIV-associated neuropathological mechanisms.

Original languageEnglish
Pages (from-to)435-444
Number of pages10
JournalJournal of NeuroVirology
Volume16
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

HIV
Basal Ganglia
Magnetic Resonance Spectroscopy
Creatine
Brain
Magnetic Resonance Imaging
Frontal Lobe
Inositol
Temporal Lobe
Choline
Glutamine
Thalamus
Neuroglia
Atrophy
Dementia
N-acetylaspartate
Glutamic Acid
Acquired Immunodeficiency Syndrome
History
White Matter

Keywords

  • brain
  • cerebral metabolites
  • cortical volume
  • HIV
  • magnetic resonance spectroscopy
  • morphometry
  • subcortical volume

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Neurology

Cite this

Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. / Cohen, Ronald A.; Harezlak, Jaroslaw; Gongvatana, Assawin; Buchthal, Steven; Schifitto, Giovanni; Clark, Uraina; Paul, Robert; Taylor, Michael; Thompson, Paul; Tate, David; Alger, Jeffery; Brown, Mark; Zhong, Jianhui; Campbell, Thomas; Singer, Elyse; Daar, Eric; McMahon, Deborah; Tso, Yuen; Yiannoutsos, Constantin; Navia, Bradford.

In: Journal of NeuroVirology, Vol. 16, No. 6, 12.2010, p. 435-444.

Research output: Contribution to journalArticle

Cohen, RA, Harezlak, J, Gongvatana, A, Buchthal, S, Schifitto, G, Clark, U, Paul, R, Taylor, M, Thompson, P, Tate, D, Alger, J, Brown, M, Zhong, J, Campbell, T, Singer, E, Daar, E, McMahon, D, Tso, Y, Yiannoutsos, C & Navia, B 2010, 'Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes', Journal of NeuroVirology, vol. 16, no. 6, pp. 435-444. https://doi.org/10.3109/13550284.2010.520817
Cohen, Ronald A. ; Harezlak, Jaroslaw ; Gongvatana, Assawin ; Buchthal, Steven ; Schifitto, Giovanni ; Clark, Uraina ; Paul, Robert ; Taylor, Michael ; Thompson, Paul ; Tate, David ; Alger, Jeffery ; Brown, Mark ; Zhong, Jianhui ; Campbell, Thomas ; Singer, Elyse ; Daar, Eric ; McMahon, Deborah ; Tso, Yuen ; Yiannoutsos, Constantin ; Navia, Bradford. / Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. In: Journal of NeuroVirology. 2010 ; Vol. 16, No. 6. pp. 435-444.
@article{ae143676825d42eea73f494b391207a2,
title = "Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes",
abstract = "Cerebral metabolite disturbances occur among human immunodeficiency virus (HIV)-infected people, and are thought to reflect neuropathology, including proinflammatory processes, and neuronal loss. HIV-associated cortical atrophy continues to occur, though its basis is not well understood, and the relationship of cerebral metabolic disturbance to structural brain abnormalities in HIV has not been well delineated. We hypothesized that metabolite disturbances would be associated with reduced cortical and subcortical volumes. Cerebral volumes were measured in 67 HIV-infected people, including 10 people with mild dementia (acquired immunodeficiency syndrome [AIDS] dimentia complex [ADC] stage >1) via automated magnetic resonance imaging (MRI) segmentation. Magnetic resonance spectroscopy (MRS) was used to measure levels of cerebral metabolites N-acetylaspartate (NAA), myo-inositol (MI), choline-containing compounds (Cho), glutamate/glutamine (Glx), and creatine (Cr) from three brain regions (frontal gray matter, frontal white matter, basal ganglia). Analyses were conducted to examine the associations between MRS and cerebral volumetric measures using both absolute and relative metabolite concentrations. NAA in the mid-frontal gray matter was most consistently associated with cortical (global, frontal, and parietal), ventricular, and caudate volumes based on analysis of absolute metabolite levels, whereas temporal lobe volume was associated with basal ganglia NAA and Glx, and Cho concentrations in the frontal cortex and basal ganglia. Hippocampal volume was associated with frontal white matter NAA, whereas thalamic volume was associated with both frontal white matter NAA and basal ganglia Glx. Analyses of relative metabolite concentrations (referenced to Cr) yielded weaker effects, although more metabolites were retained as significant predictors in the models than the analysis of absolute concentrations. These findings demonstrate that reduced cortical and subcortical volumes, which have been previously found to be linked to HIV status and history, are also strongly associated with the degree of cerebral metabolite disturbance observed via MRS. Reduced cortical and hippocampal volumes were most strongly associated with decreased NAA, though reduced Glx also tended to be associated with reduced cortical and subcortical volumes (caudate and thalamus) as well, suggesting both neuronal and glial disturbances. Interestingly, metabolite-volumetric relationships were not limited to the cortical region from which MRS was measured, possibly reflecting shared pathophysiological processes. The relationships between Cho and volumetric measures suggest a complicated relationship possibly related to the effects of inflammatory processes on brain volume. The findings demonstrate the relationship between MRI-derived measures of cerebral metabolite disturbances and structural brain integrity, which has implication in understanding HIV-associated neuropathological mechanisms.",
keywords = "brain, cerebral metabolites, cortical volume, HIV, magnetic resonance spectroscopy, morphometry, subcortical volume",
author = "Cohen, {Ronald A.} and Jaroslaw Harezlak and Assawin Gongvatana and Steven Buchthal and Giovanni Schifitto and Uraina Clark and Robert Paul and Michael Taylor and Paul Thompson and David Tate and Jeffery Alger and Mark Brown and Jianhui Zhong and Thomas Campbell and Elyse Singer and Eric Daar and Deborah McMahon and Yuen Tso and Constantin Yiannoutsos and Bradford Navia",
year = "2010",
month = "12",
doi = "10.3109/13550284.2010.520817",
language = "English",
volume = "16",
pages = "435--444",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes

AU - Cohen, Ronald A.

AU - Harezlak, Jaroslaw

AU - Gongvatana, Assawin

AU - Buchthal, Steven

AU - Schifitto, Giovanni

AU - Clark, Uraina

AU - Paul, Robert

AU - Taylor, Michael

AU - Thompson, Paul

AU - Tate, David

AU - Alger, Jeffery

AU - Brown, Mark

AU - Zhong, Jianhui

AU - Campbell, Thomas

AU - Singer, Elyse

AU - Daar, Eric

AU - McMahon, Deborah

AU - Tso, Yuen

AU - Yiannoutsos, Constantin

AU - Navia, Bradford

PY - 2010/12

Y1 - 2010/12

N2 - Cerebral metabolite disturbances occur among human immunodeficiency virus (HIV)-infected people, and are thought to reflect neuropathology, including proinflammatory processes, and neuronal loss. HIV-associated cortical atrophy continues to occur, though its basis is not well understood, and the relationship of cerebral metabolic disturbance to structural brain abnormalities in HIV has not been well delineated. We hypothesized that metabolite disturbances would be associated with reduced cortical and subcortical volumes. Cerebral volumes were measured in 67 HIV-infected people, including 10 people with mild dementia (acquired immunodeficiency syndrome [AIDS] dimentia complex [ADC] stage >1) via automated magnetic resonance imaging (MRI) segmentation. Magnetic resonance spectroscopy (MRS) was used to measure levels of cerebral metabolites N-acetylaspartate (NAA), myo-inositol (MI), choline-containing compounds (Cho), glutamate/glutamine (Glx), and creatine (Cr) from three brain regions (frontal gray matter, frontal white matter, basal ganglia). Analyses were conducted to examine the associations between MRS and cerebral volumetric measures using both absolute and relative metabolite concentrations. NAA in the mid-frontal gray matter was most consistently associated with cortical (global, frontal, and parietal), ventricular, and caudate volumes based on analysis of absolute metabolite levels, whereas temporal lobe volume was associated with basal ganglia NAA and Glx, and Cho concentrations in the frontal cortex and basal ganglia. Hippocampal volume was associated with frontal white matter NAA, whereas thalamic volume was associated with both frontal white matter NAA and basal ganglia Glx. Analyses of relative metabolite concentrations (referenced to Cr) yielded weaker effects, although more metabolites were retained as significant predictors in the models than the analysis of absolute concentrations. These findings demonstrate that reduced cortical and subcortical volumes, which have been previously found to be linked to HIV status and history, are also strongly associated with the degree of cerebral metabolite disturbance observed via MRS. Reduced cortical and hippocampal volumes were most strongly associated with decreased NAA, though reduced Glx also tended to be associated with reduced cortical and subcortical volumes (caudate and thalamus) as well, suggesting both neuronal and glial disturbances. Interestingly, metabolite-volumetric relationships were not limited to the cortical region from which MRS was measured, possibly reflecting shared pathophysiological processes. The relationships between Cho and volumetric measures suggest a complicated relationship possibly related to the effects of inflammatory processes on brain volume. The findings demonstrate the relationship between MRI-derived measures of cerebral metabolite disturbances and structural brain integrity, which has implication in understanding HIV-associated neuropathological mechanisms.

AB - Cerebral metabolite disturbances occur among human immunodeficiency virus (HIV)-infected people, and are thought to reflect neuropathology, including proinflammatory processes, and neuronal loss. HIV-associated cortical atrophy continues to occur, though its basis is not well understood, and the relationship of cerebral metabolic disturbance to structural brain abnormalities in HIV has not been well delineated. We hypothesized that metabolite disturbances would be associated with reduced cortical and subcortical volumes. Cerebral volumes were measured in 67 HIV-infected people, including 10 people with mild dementia (acquired immunodeficiency syndrome [AIDS] dimentia complex [ADC] stage >1) via automated magnetic resonance imaging (MRI) segmentation. Magnetic resonance spectroscopy (MRS) was used to measure levels of cerebral metabolites N-acetylaspartate (NAA), myo-inositol (MI), choline-containing compounds (Cho), glutamate/glutamine (Glx), and creatine (Cr) from three brain regions (frontal gray matter, frontal white matter, basal ganglia). Analyses were conducted to examine the associations between MRS and cerebral volumetric measures using both absolute and relative metabolite concentrations. NAA in the mid-frontal gray matter was most consistently associated with cortical (global, frontal, and parietal), ventricular, and caudate volumes based on analysis of absolute metabolite levels, whereas temporal lobe volume was associated with basal ganglia NAA and Glx, and Cho concentrations in the frontal cortex and basal ganglia. Hippocampal volume was associated with frontal white matter NAA, whereas thalamic volume was associated with both frontal white matter NAA and basal ganglia Glx. Analyses of relative metabolite concentrations (referenced to Cr) yielded weaker effects, although more metabolites were retained as significant predictors in the models than the analysis of absolute concentrations. These findings demonstrate that reduced cortical and subcortical volumes, which have been previously found to be linked to HIV status and history, are also strongly associated with the degree of cerebral metabolite disturbance observed via MRS. Reduced cortical and hippocampal volumes were most strongly associated with decreased NAA, though reduced Glx also tended to be associated with reduced cortical and subcortical volumes (caudate and thalamus) as well, suggesting both neuronal and glial disturbances. Interestingly, metabolite-volumetric relationships were not limited to the cortical region from which MRS was measured, possibly reflecting shared pathophysiological processes. The relationships between Cho and volumetric measures suggest a complicated relationship possibly related to the effects of inflammatory processes on brain volume. The findings demonstrate the relationship between MRI-derived measures of cerebral metabolite disturbances and structural brain integrity, which has implication in understanding HIV-associated neuropathological mechanisms.

KW - brain

KW - cerebral metabolites

KW - cortical volume

KW - HIV

KW - magnetic resonance spectroscopy

KW - morphometry

KW - subcortical volume

UR - http://www.scopus.com/inward/record.url?scp=78649687236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649687236&partnerID=8YFLogxK

U2 - 10.3109/13550284.2010.520817

DO - 10.3109/13550284.2010.520817

M3 - Article

C2 - 20961212

AN - SCOPUS:78649687236

VL - 16

SP - 435

EP - 444

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 6

ER -